Please assess the completion status of the following clinical trial:

Trial Title: One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: SINGLE
- Phase: EARLY_PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy caucasian subjects of both sexes between the ages of 24-35 years, who are able to spend one week on the Clinical \& Translational Research Center at the University of Pittsburgh Medical Center (UPMC) Montefiore~Exclusion Criteria:~* Pregnancy~* Any cardiac, renal, pulmonary, endocrine, musculoskeletal, hepatic, hematological, malignant or rheumatologic diseases~* Body mass index great than 30~* Anemia~* Significant alcohol or drug abuse~* Baseline hypotension or hypertension~* Abnormal screening labs~* Use of certain chronic medications excluding oral contraceptives~* Receiving an investigational drug in the last 90 days~* Previously receiving PTH or PTHrP~* African-American race

- Gender: ALL
- Minimum Age: 24 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- PTHrP(1-36) 2 pmol/kg/hr (Type: EXPERIMENTAL): PTHrP(1-36) at 2 picomoles/kg/hr for one week.
- PTHrP (1-36) 4 pmol/kg/hr (Type: EXPERIMENTAL): PTHrP(1-36) at 4 picomoles/kg/hr for one week.
- PTHrP(1-36) 5 pmol/kg/hr (Type: EXPERIMENTAL): PTHrP(1-36) at 5 picomoles/kg/hr for one week.
- PTHrP(1-36) 6 pmol/kg/hr (Type: EXPERIMENTAL): PTHrP(1-36) at 6 picomoles/kg/hr for one week.

Based on this trial design, predict the completion outcome and termination type (if applicable).